Literature DB >> 32420921

Heterogeneity of COVID-19 outbreak in Italy.

Bruno Alessandro Rivieccio1, Ester Luconi2, Patrizia Boracchi3, Elena Pariani4, Luisa Romanò5, Silvia Salini6, Silvana Castaldi7, Elia Biganzoli8, Massimo Galli9.   

Abstract

An outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) started in December 2019 in China and was declared a pandemic on 11.03.2020 by WHO. Italy is one of the most afflicted Country by this epidemic with 136,110 confirmed cases and 16,654 deaths on 9.4.2020 (at the same date, the Ministry of Health was reporting 143,626 cases).  During these few months the National Health Service have made a great effort to cope with the increasing request of intensive care beds and all the elective activities in hospital have been suspended. Data from the different Italian regions shows different patterns of positive and dead for this syndrome. Moreover, striking differences of the observed lethality of the infections among different areas were immediately evident from the epidemic reports. It will be of critical relevance to understand the expected evolution of the first lock-down phase, driving the exhaustion of the Covid-19 outbreak.(www.actabiomedica.it).

Entities:  

Mesh:

Year:  2020        PMID: 32420921      PMCID: PMC7569642          DOI: 10.23750/abm.v91i2.9579

Source DB:  PubMed          Journal:  Acta Biomed        ISSN: 0392-4203


An outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) started in December 2019 in China and was declared a pandemic on 11.03.2020 by WHO (1). Italy is one of the most afflicted Country by this epidemic with 136,110 confirmed cases and 16,654 deaths (2) on 9.04.2020 (at the same date, the Ministry of Health was reporting 143,626 cases). Among the total cases, 14,066 (10.3%) were healthcare workers. Among the 96,877 currently positive according to the Ministry of Health, 3,605 (3.7%) were in intensive care units (ICU), 28,399 (29.3%) were hospitalized and the remaining 64,873 (67%) were isolated at home. In Italy, from 21 February 2020, most of the cases were declared in Lombardia region and in the surrounding Regions Veneto, Piemonte, Emilia-Romagna and the distant Marche. According to molecular data and estimation from the outbreak curves, the occurrence of first undetected infections were dated at January 26 coming from Germany (3). The Italian Government disposed different measures to hamper the diffusion of the syndrome such as closing all schools and universities, theatres, cinemas and all the business activities except for food delivery (4). During these few months the National Health Service have made a great effort to cope with the increasing request of intensive care beds and all the elective activities in hospital have been suspended. Data from the different Italian regions shows different patterns of positive and dead for this syndrome (5,6). Moreover, striking differences of the observed lethality of the infections among different areas were immediately evident from the epidemic reports. As we look at the data of Bergamo, Brescia, Milano or Lodi including Codogno (the first hot spot “red area” in Italy) some hypotheses might be supposed. A very first hypothesis is related to the demographic age structure of the population in different areas with possibly different susceptibility to the infectious disease and progression. We might speculate that overabundant elderly population and the contacts with younger people act as the contagion’s vector. Social patterns, especially of the elderly and younger population, who would meet in normal social contexts, may have had a particularly important role. It is important to clarify the role of public healthcare measures across regions, such as the testing procedures adopted for symptomatic and exposed people, the relation of healthcare practice for the elderly or frail people with major hospital institutions and the interactions in normal social life of the considered communities. In addition, the availability of personal protective equipment is another important issue. Protective masks, from the beginning of the epidemic, were becoming scarce, they were sold at an increasing price and many were even not certified. Moreover, inhomogeneous indications about mask protection were provided since the beginning of the outbreak, WHO was recommending the use of masks only for the infected people and health care practitioners, whereas in the USA the CDC was recommending the use of surgical masks or any face tissue protection for all, forbidding the use of professional masks for normal people. This situation was faced also by the residential home for elderly people which were affected by very high lethality. Looking at the tables at March 19 (table 1) and April 9 (table 2), striking differences are noticeable at both times regarding the lethality proportion between Lombardia and Emilia-Romagna compared to the other Italian regions and, at the same time, the proportion of infected health workers appears strikingly high in these two regions. Moreover the increase of lethality in Lombardia was particularly high. Looking at the age distribution of infected people, the Veneto region reports younger cases. This might partly explain the differences in lethality showing the results of a different healthcare management of the outbreak, together with the actual underestimation of infected cases in Lombardia and Emilia-Romagna. However, given the similar demographic age structure of these regions, the role of hospitals together with a different healthcare practice outside the hospital would explain the observed heterogeneity in the epidemic spread, suggesting improved strategies for the protection of the elderly and frail people at major risk of disease contagion and following spread. In the next future, it will be important to set priorities in preventive measures to stop the spread of the epidemic diffusion, paying attention to social interaction models as a major target. The role of local healthcare systems, with specific attention to early disease treatment at home rather than hospitalization, was actually showing a paradigmatic reversal of the traditional modern role of hospitals. Their major weakness in the outbreak is calling for the empowerment of community and territorial medicine with trained general practitioners and specialized healthcare personnel. It will be of critical relevance to understand the expected evolution of the first lock-down phase, driving the exhaustion of the Covid-19 outbreak.
Table 1.

Data on epidemic by National Institute of Health an Ministery of Health same day

ISS data 19/03/2020 (1)Ministry of Health data 19/03/2020 (2)
LombardiaVenetoEmilia-R.PiemonteMarcheLombardiaVenetoEmilia-R.PiemonteMarche
Population100605744905854445947743564061525271Population100605744905854445947743564061525271
km223863.6518345.3522452.7825387.079401.38km223863.6518345.3522452.7825387.079401.38
Age classCases n (%)
0-9101 (0.5%)28 (0.8%)15 (0.3%)6 (0.8%)1 (0.1%)
10-1998 (0.5%)40 (1.1%)42 (0.9%)4 (0.5%)12 (0.7%)
20-29633 (3.2%)238 (6.5%)159 (3.5%)36 (4.8%)37 (2.2%)
30-391278 (6.4%)322 (8.8%)323 (7.2%)44 (5.9%)96 (5.7%)
40-492268 (11.4%)508 (13.9%)622 (13.9%)84 (11.3%)191 (11.3%)
50-593750 (18.9%)808 (22.2%)782 (17.5%)122 (16.4%)310 (18.4%)
60-693629 (18.3%)603 (16.5%)750 (16.7%)125 (16.8%)304 (18%)
70-794419 (22.2%)500 (13.7%)930 (20.8%)164 (22%)321 (19.1%)
80-893154 (15.9%)448 (12.3%)704 (15.7%)124 (16.6%)309 (18.3%)
>=90527 (2.7%)147 (4%)153 (3.4%)31 (4.2%)87 (5.2%)
Unknown25 (0.1%)3 (0.1%)6 (0.8%)17 (1%)
Total Cases19882364544807461685Total Cases198843484521429321737
Deaths21731214536235Deaths2168115531175115
Health Workers2808742962027
Median Age6458646566
Lethality95% CI0,109(0.105-0.113)0.033(0.027-0.039)0.101(0.092-0110)0.083(0.064-0.105)0.021(0.014-0.028)Lethality95% CI0.109(0.104-0.113)0.033(0.027-0.039)0.1020.093-0.110)0.060(0.051-0.068)0.066(0.055-0.078)
HW/Cases95% CI0.141(0.136-0.1462)0.020(0.016-0.025)0.066(0.059-0.073)0.027(0.016-0.041)0.016(0.010-0.023)
Rates x100,000Rates x100,000
Infection197.674.3100.517.1110.5Infection197.671.0116.967.3113.9
Mortality21.62.510.21.42.3Mortality21.52.311.94.07.5

(1) https://www.epicentro.iss.it/coronavirus/bollettino/Bolletino-sorveglianza-integrata-COVID-19_19-marzo-2020_appendix.pdf

(2) https://github.com/pcm-dpc/COVID-19/tree/master/schede-riepilogative

Table 2.

Data on epidemic by National Institute of Health an Ministery of Health same day

ISS data 09/04/2020 (1)Ministry of Health data 09/04/2020 (2)
LombardiaVenetoEmilia-R.PiemonteMarcheLombardiaVenetoEmilia-R.PiemonteMarche
Population100605744905854445947743564061525271Population100605744905854445947743564061525271
km223863.6518345.3522452.7825387.079401.38km223863.6518345.3522452.7825387.079401.38
Age classCases n (%)
0-9235 (0.4%)122 (0.9%)90 (0.5%)53 (0.4%)33 (0.7%)
10-19215 (0.4%) 224 (1.7%) 191 (1.1%)62 (0.5%) 43 (0.9%)
20-291887 (3.4%)900 (7%)844 (4.6%)525 (4.2%)186 (3.9%)
30-39 3381 (6.2%)1106 (8.5%)1399 (7.7%)836 (6.7%)344 (7.2%)
40-496593 (12%) 1811 (14%)2486 (13.7%)1577 (12.7%)604 (12.7%)
50-5910415 (19%)2656 (20.5%)3368 (18.5%)2436 (19.7%) 887 (18.7%)
60-699351 (17.1%) 1751 (13.5%)2797 (15.4%)1952 (15.8%)740 (15.6%)
70-7910862 (19.8%)1592 (12.3%)3055 (16.8%)2104 (17%)769 (16.2%)
80-899505 (17.3%)1887 (14.6%)2926 (16.1%)2211 (17.8%) 820 (17.2%)
>=902336 (4.3%)890 (6.9%)1031 (5.7%)633 (5.1%)320 (6.7%)
Unknown21 (0%)1 (0%)1 (0%)3 (0%)9 (0.2%)
Total Cases548011294018188123924755Total Cases548021293318677145224955
Deaths973175622211210361Deaths1002275623161454669
Health WorkersNANANANANA
Median Age6458626363
Lethality95% CI0.178(0.174- 0.181)0.058(0.054- 0.063)0.122(0.117- 0.127)0.098 (0.092-0.103)0.076(0.069-0.084)Lethality95% CI0.183(0.180- 0.186)0.058(0.054-0.063)0.124(0.119-0.129)0.1(0.095,0.105)0.135(0.126,0.145)
HW/CasesNANANANANA
95% CI
Rates x100,000Rates x100,000
Infection544.7263.8407.9284.5311.7Infection 544.7263.6418.8333.3324.9
Mortality96.715.449.827.823.7Mortality99.615.451.933.443.9

(1) https://www.epicentro.iss.it/coronavirus/bollettino/Bolletino-sorveglianza-integrata-COVID-19_19-marzo-2020_appendix.pdf

(2) https://github.com/pcm-dpc/COVID-19/tree/master/schede-riepilogative

Data on epidemic by National Institute of Health an Ministery of Health same day (1) https://www.epicentro.iss.it/coronavirus/bollettino/Bolletino-sorveglianza-integrata-COVID-19_19-marzo-2020_appendix.pdf (2) https://github.com/pcm-dpc/COVID-19/tree/master/schede-riepilogative Data on epidemic by National Institute of Health an Ministery of Health same day (1) https://www.epicentro.iss.it/coronavirus/bollettino/Bolletino-sorveglianza-integrata-COVID-19_19-marzo-2020_appendix.pdf (2) https://github.com/pcm-dpc/COVID-19/tree/master/schede-riepilogative
  2 in total

1.  The spread of COVID-19 in six western metropolitan regions: a false myth on the excess of mortality in Lombardy and the defense of the city of Milan.

Authors:  Carlo Signorelli; Anna Odone; Vincenza Gianfredi; Eleonora Bossi; Daria Bucci; Aurea Oradini-Alacreu; Beatrice Frascella; Michele Capraro; Federica Chiappa; Lorenzo Blandi; Fabio Ciceri
Journal:  Acta Biomed       Date:  2020-05-11

2.  Early phylogenetic estimate of the effective reproduction number of SARS-CoV-2.

Authors:  Alessia Lai; Annalisa Bergna; Carla Acciarri; Massimo Galli; Gianguglielmo Zehender
Journal:  J Med Virol       Date:  2020-03-03       Impact factor: 2.327

  2 in total
  17 in total

1.  Are Epidemiological Estimates Able to Describe the Ability of Health Systems to Cope with COVID-19 Epidemic?

Authors:  Silvana Castaldi; Ester Luconi; Bruno Alessandro Rivieccio; Massimo Galli; Elia Biganzoli; Patrizia Boracchi; Giuseppe Marano; Elena Pariani; Luisa Romano; Francesco Auxilia; Federica Nicolussi; Alessandra Micheletti; Giancarlo Manzi; Silvia Salini
Journal:  Risk Manag Healthc Policy       Date:  2021-05-31

2.  Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome.

Authors:  Juan Gómez; Guillermo M Albaiceta; Marta García-Clemente; Carlos López-Larrea; Laura Amado-Rodríguez; Inés Lopez-Alonso; Tamara Hermida; Ana I Enriquez; Pablo Herrero; Santiago Melón; Marta E Alvarez-Argüelles; José A Boga; Susana Rojo-Alba; Elías Cuesta-Llavona; Victoria Alvarez; Rebeca Lorca; Eliecer Coto
Journal:  Gene       Date:  2020-08-31       Impact factor: 3.688

3.  Characteristics of First Cases of Coronavirus Disease 2019 and the Effort to Prevent the Early Spread of COVID-19 in Saudi Arabia.

Authors:  Zuhair S Natto; Heba K Alshaeri
Journal:  Risk Manag Healthc Policy       Date:  2021-01-26

4.  COVID-19: new scenario old problems.

Authors:  Francesco Auxilia; Anna Maraschini; Patrizia Bono; Riccardo Ungaro; Ester Luconi; Elia Biganzoli; Silvana Castaldi
Journal:  Acta Biomed       Date:  2020-07-20

5.  CoViD-19, learning from the past: A wavelet and cross-correlation analysis of the epidemic dynamics looking to emergency calls and Twitter trends in Italian Lombardy region.

Authors:  Bruno Alessandro Rivieccio; Alessandra Micheletti; Manuel Maffeo; Matteo Zignani; Alessandro Comunian; Federica Nicolussi; Silvia Salini; Giancarlo Manzi; Francesco Auxilia; Mauro Giudici; Giovanni Naldi; Sabrina Gaito; Silvana Castaldi; Elia Biganzoli
Journal:  PLoS One       Date:  2021-02-25       Impact factor: 3.240

6.  Monitoring emergency calls and social networks for COVID-19 surveillance. To learn for the future: The outbreak experience of the Lombardia region in Italy.

Authors:  Silvana Castaldi; Manuel Maffeo; Bruno Alessandro Rivieccio; Matteo Zignani; Giancarlo Manzi; Federica Nicolussi; Silvia Salini; Alessandra Micheletti; Sabrina Gaito; Elia Biganzoli
Journal:  Acta Biomed       Date:  2020-07-20

Review 7.  The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNET.

Authors:  Rosaria Talarico; Silvia Aguilera; Tobias Alexander; Zahir Amoura; Ana M Antunes; Laurent Arnaud; Tadej Avcin; Lorenzo Beretta; Stefano Bombardieri; Gerd R Burmester; Sara Cannizzo; Lorenzo Cavagna; Benjamin Chaigne; Alain Cornet; Nathalie Costedoat-Chalumeau; Andrea Doria; Alessandro Ferraris; Rebecca Fischer-Betz; João E Fonseca; Charissa Frank; Andrea Gaglioti; Ilaria Galetti; Jürgen Grunert; Vera Guimarães; Eric Hachulla; Frederic Houssiau; Luca Iaccarino; Thomas Krieg; Marteen Limper; Fransiska Malfait; Xavier Mariette; Diana Marinello; Thierry Martin; Lisa Matthews; Marco Matucci-Cerinic; Alain Meyer; Carlomaurizio Montecucco; Luc Mouthon; Ulf Müller-Ladner; Simona Rednic; Vasco C Romão; Matthias Schneider; Vanessa Smith; Alberto Sulli; Farah Tamirou; Domenica Taruscio; Anna V Taulaigo; Enrique Terol; Angela Tincani; Simone Ticciati; Giuseppe Turchetti; P Martin van Hagen; Jacob M van Laar; Ana Vieira; Jeska K de Vries-Bouwstra; Maurizio Cutolo; Marta Mosca
Journal:  Nat Rev Rheumatol       Date:  2021-01-06       Impact factor: 32.286

8.  Effects of Bariatric Surgery on COVID-19: a Multicentric Study from a High Incidence Area.

Authors:  Federico Marchesi; Marina Valente; Matteo Riccò; Matteo Rottoli; Edoardo Baldini; Fouzia Mecheri; Stefano Bonilauri; Sergio Boschi; Paolo Bernante; Andrea Sciannamea; Jessica Rolla; Alice Francescato; Ruggero Bollino; Concetto Cartelli; Andrea Lanaia; Francesca Anzolin; Paolo Del Rio; Diletta Fabbi; Gabriele Luciano Petracca; Francesco Tartamella; Giorgio Dalmonte
Journal:  Obes Surg       Date:  2021-01-08       Impact factor: 3.479

9.  COVID-19: What happened to the healthcare workers of a research and teaching hospital in Milan, Italy?

Authors:  Dario Consonni; Lorenzo Bordini; Carlo Nava; Aldo Todaro; Giovanna Lunghi; Andrea Lombardi; Davide Magioni; Francesco De Palo; Lidia Guerrieri; Michele Gatti; Daniele Serra; Marco Polonioli; Simone Pratò; Antonio Muscatello; Alessandra Bandera; Francesco Auxilia; Silvana Castaldi
Journal:  Acta Biomed       Date:  2020-09-07

10.  Hospital Acquired Infections in COVID-19 patients in sub intensive care unit.

Authors:  Silvana Castaldi; Ester Luconi; Giuseppe Marano; Francesco Auxilia; Anna Maraschini; Patrizia Bono; Riccardo Ungaro; Alessandra Bandera; Patrizia Boracchi; Elia Biganzoli
Journal:  Acta Biomed       Date:  2020-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.